{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T07:59:42Z","timestamp":1790495982446,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1016\/j.cgh.2005.11.013","type":"journal-article","created":{"date-parts":[[2006,3,9]],"date-time":"2006-03-09T09:00:33Z","timestamp":1141894833000},"page":"325-334","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":160,"title":["Oral p38 Mitogen-Activated Protein Kinase Inhibition With BIRB 796 for Active Crohn\u2019s Disease: A Randomized, Double-Blind, Placebo-Controlled Trial"],"prefix":"10.1016","volume":"4","author":[{"given":"Stefan","family":"Schreiber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Feagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert","family":"D\u2019Haens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean\u2013Frederic","family":"Colombel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karel","family":"Geboes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhail","family":"Yurcov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasily","family":"Isakov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleg","family":"Golovenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles N.","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diether","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor","family":"Winter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Meier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan","family":"Yong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Steffgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2005.11.013_bib1","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S0899-9007(98)00083-5","article-title":"Local and systemic effects of macrophage cytokines in intestinal inflammation","volume":"14","author":"Murch","year":"1998","journal-title":"Nutrition"},{"key":"10.1016\/j.cgh.2005.11.013_bib2","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1111\/j.1572-0241.1999.01288.x","article-title":"Clinical relevance of serum interleukin-6 in Crohn\u2019s disease","volume":"94","author":"Reinisch","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2005.11.013_bib3","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1365-2249.1993.tb05997.x","article-title":"Enhanced secretion of tumor necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn\u2019s disease","volume":"94","author":"Reinecker","year":"1993","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.cgh.2005.11.013_bib4","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0140-6736(98)03339-X","article-title":"Tumor necrosis factor alpha and interleukin 1beta in relapse of Crohn\u2019s disease","volume":"353","author":"Schreiber","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2005.11.013_bib5","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1136\/gut.34.12.1705","article-title":"Location of tumour necrosis factor alpha by immunohistochemistry in chronic inflammatory bowel disease","volume":"34","author":"Murch","year":"1993","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2005.11.013_bib6","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0016-5085(92)91096-M","article-title":"Recombinant interleukin-1 receptor antagonist blocks the proinflammatory activity of endogenous interleukin-1 in rabbit immune colitis","volume":"103","author":"Cominelli","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2005.11.013_bib7","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/75068","article-title":"Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation","volume":"6","author":"Atreya","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.cgh.2005.11.013_bib8","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/1074-7613(94)90045-0","article-title":"Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells","volume":"1","author":"Powrie","year":"1994","journal-title":"Immunity"},{"key":"10.1016\/j.cgh.2005.11.013_bib9","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1056\/NEJM199710093371502","article-title":"A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn\u2019s disease","volume":"337","author":"Targan","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2005.11.013_bib10","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0140-6736(02)08512-4","article-title":"Maintenance infliximab for Crohn\u2019s disease","volume":"359","author":"Hanauer","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2005.11.013_bib11","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1056\/NEJM199905063401804","article-title":"Infliximab for the treatment of fistulas in patients with Crohn\u2019s disease","volume":"340","author":"Present","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2005.11.013_bib12","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/S0140-6736(00)02871-3","article-title":"Mechanism in failure of infliximab for Crohn\u2019s disease","volume":"356","author":"Nikolaus","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2005.11.013_bib13","series-title":"Recent advances in the pathophysiology and management of inflammatory bowel diseases and digestive endocrine tumors","first-page":"116","article-title":"A review of biotechnology therapies for inflammatory bowel disease","author":"Sandborn","year":"1999"},{"key":"10.1016\/j.cgh.2005.11.013_bib14","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1152\/physrev.2001.81.2.807","article-title":"Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation","volume":"81","author":"Kyriakis","year":"2001","journal-title":"Physiol Rev"},{"key":"10.1016\/j.cgh.2005.11.013_bib15","doi-asserted-by":"crossref","first-page":"5342","DOI":"10.4049\/jimmunol.168.10.5342","article-title":"p38 mitogen-activated protein kinase is activated and linked to TNF-alpha signaling in inflammatory bowel disease","volume":"168","author":"Waetzig","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.cgh.2005.11.013_bib16","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/372739a0","article-title":"A protein kinase involved in the regulation of inflammatory cytokine biosynthesis","volume":"372","author":"Lee","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.cgh.2005.11.013_bib17","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1136\/gut.52.1.144","article-title":"Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti-inflammatory targets","volume":"52","author":"Hommes","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2005.11.013_bib18","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/nsb770","article-title":"Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site","volume":"9","author":"Pargellis","year":"2002","journal-title":"Nat Struct Biol"},{"key":"10.1016\/j.cgh.2005.11.013_bib19","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.4049\/jimmunol.168.8.4070","article-title":"Anti-inflammatory effects of a p38 mitogen-activated protein kinase inhibitor during human endotoxemia","volume":"168","author":"Branger","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.cgh.2005.11.013_bib20","first-page":"983","article-title":"Development and validation of an endoscopic index of the severity for Crohn\u2019s disease","volume":"30","year":"1989","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2005.11.013_bib21","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0016-5085(98)70476-7","article-title":"Early lesions of Recurrent Crohn\u2019s disease caused by infusion of intestinal contents in excluded ileum","volume":"114","author":"D\u2032Haens","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2005.11.013_bib22","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0016-5085(94)90585-1","article-title":"Quality of life","volume":"106","author":"Irvine","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2005.11.013_bib23","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1053\/gast.2002.30770","article-title":"Inhibition of stress-activated MAP kinase induces clinical improvement in moderate to severe Crohn\u2019s disease","volume":"122","author":"Hommes","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2005.11.013_bib24","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1006\/cimm.1998.1448","article-title":"A specific inhibitor of the p38 mitogen activated protein kinase affects differentially the production of various cytokines by activated T cells","volume":"192","author":"Koprak","year":"1999","journal-title":"Cell Immunol"},{"key":"10.1016\/j.cgh.2005.11.013_bib25","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0092-8674(93)80068-P","article-title":"Interleukin-10-deficient mice develop chronic enterocolitis","volume":"75","author":"Kuhn","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.cgh.2005.11.013_bib26","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1053\/gast.2000.20196","article-title":"Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn\u2019s disease","volume":"119","author":"Schreiber","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2005.11.013_bib27","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1016\/S0016-5085(03)00382-2","article-title":"Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn\u2019s disease","volume":"124","author":"van den Brande","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2005.11.013_bib28","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1136\/gut.53.1.70","article-title":"Defective mucosal T cell death is sustainably reverted by Infliximab in a caspase dependent pathway in Crohn\u2019s disease","volume":"53","author":"Di Sabatino","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2005.11.013_bib29","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1053\/gast.2001.28674","article-title":"Etanercept for active Crohn\u2019s disease","volume":"121","author":"Sandborn","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2005.11.013_bib30","first-page":"314","article-title":"Differential modulation of p38 mitogen activated protein kinase and STAT3 signalling pathways by infliximab and etanercept in intestinal T cells from patients with Crohn\u2019s disease","volume":"54","author":"Rosenstiel","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2005.11.013_bib31","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1136\/gut.50.4.507","article-title":"Dichotomal role of inhibition of p38 MAPK with SB 203580 in experimental colitis","volume":"50","author":"ten Hove","year":"2002","journal-title":"Gut"},{"issue":"Suppl III","key":"10.1016\/j.cgh.2005.11.013_bib32","first-page":"A37","article-title":"Decreased activity of mitogen-activated protein kinases (MAPK) p38 and JNK in patients with inflammatory bowel diseases without therapeutic effect of p38 inhibitor in experimental model of colitis","volume":"51","author":"Malamut","year":"2002","journal-title":"Gut"},{"issue":"Suppl 2","key":"10.1016\/j.cgh.2005.11.013_bib33","first-page":"A464","article-title":"Semapimod treatment of Crohn\u2019s disease","volume":"126","author":"Buchman","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2005.11.013_bib34","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1053\/j.gastro.2004.01.024","article-title":"A meta-analysis of the placebo rates of remission and response in clinical trials of active Crohn\u2019s disease","volume":"126","author":"Su","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2005.11.013_bib35","first-page":"166","article-title":"A double-blind placebo-controlled trial of VX-745, an oral P38 mitogen activated protein kinase (MAPK) inhibitor, in patients with rheumatoid arthritis (RA)","volume":"61","author":"Weisman","year":"2002","journal-title":"Ann Rheum Dis"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356505011018?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356505011018?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:57:46Z","timestamp":1761541066000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356505011018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S1542356505011018"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2005.11.013","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral p38 Mitogen-Activated Protein Kinase Inhibition With BIRB 796 for Active Crohn\u2019s Disease: A Randomized, Double-Blind, Placebo-Controlled Trial","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2005.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 American Gastroenterological Association Institute. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}